|Deferred equity (face value)||1,050||1,020|
|Company contributions to money purchase pension plans||107||139|
|Pension cash payments||46||—|
The emoluments of individual Directors are shown in the Remuneration Report
The aggregate of emoluments of the highest paid Director was £0.81m (2016: £0.62m), which included deferred equity (at face value) of £0.25m (2016: £0.23m), Company pension contributions of £0.03m (2016: £0.05m) made to a money purchase scheme on his behalf and pension cash payments of £0.02m (2016: £nil). During the year, the highest paid Director exercised 18,000 SAYE share options (2016: nil).
The annual IFRS2 charge relating to Board deferred equity bonuses given in 2014, 2015, 2016 and 2017 was £1.13m (2016: £1.22m). The highest paid Director's element of this charge was £0.23m (2016: £0.27m).
|Number of Directors|
|Retirement benefits are accruing to the following number of Directors under|
|money purchase schemes||4||4|
|The number of Directors who exercised share options was||2||—|
See the Remuneration Report for more details.
Directors' rights to subscribe for shares in the Company are also set out in the Remuneration report.